Literature DB >> 21686076

Therapeutic immune clearance of rabies virus from the CNS.

D Craig Hooper1, Anirban Roy, Rhonda B Kean, Timothy W Phares, Darryll A Barkhouse.   

Abstract

The long-held concept that rabies infection is lethal in humans once the causative rabies virus has reached the CNS has been called into question by the recent survival of a number of patients with clinical rabies. Studies in animal models provide insight into why survival from a rabies virus infection that has spread to the CNS is possible and the immune mechanisms involved. In the CNS, both innate mechanisms capable of inhibiting virus replication and the activity of infiltrating rabies virus-specific T and B cells with the capacity to clear the virus are required. Deficiencies in the induction of either aspect of rabies immunity can lead to lethal consequences but may be overcome by novel approaches to active and passive immunization.

Entities:  

Year:  2011        PMID: 21686076      PMCID: PMC3114627          DOI: 10.2217/fvl.10.88

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  38 in total

1.  Molecular Trojan horses for blood-brain barrier drug delivery.

Authors:  William M Pardridge
Journal:  Discov Med       Date:  2006-08       Impact factor: 2.970

2.  Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection.

Authors:  Anirban Roy; Timothy W Phares; Hilary Koprowski; D Craig Hooper
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

3.  Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.

Authors:  D C Hooper; G S Scott; A Zborek; T Mikheeva; R B Kean; H Koprowski; S V Spitsin
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

4.  The role of uric acid in protection against peroxynitrite-mediated pathology.

Authors:  G S Scott; D C Hooper
Journal:  Med Hypotheses       Date:  2001-01       Impact factor: 1.538

5.  Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies.

Authors:  Jiraporn Laothamatas; Supaporn Wacharapluesadee; Boonlert Lumlertdacha; Sumate Ampawong; Vera Tepsumethanon; Shanop Shuangshoti; Patta Phumesin; Sawwanee Asavaphatiboon; Ladawan Worapruekjaru; Yingyos Avihingsanon; Nipan Israsena; Monique Lafon; Henry Wilde; Thiravat Hemachudha
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

6.  Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.

Authors:  B Dietzschold; W H Wunner; T J Wiktor; A D Lopes; M Lafon; C L Smith; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity.

Authors:  Anirban Roy; D Craig Hooper
Journal:  J Neurovirol       Date:  2008-11-18       Impact factor: 2.643

8.  Neuronal apoptosis does not play an important role in human rabies encephalitis.

Authors:  Alan C Jackson; Elizabeth Randle; Gail Lawrance; John P Rossiter
Journal:  J Neurovirol       Date:  2008-11-19       Impact factor: 2.643

9.  Suppression of cell-mediated immunity by street rabies virus.

Authors:  T J Wiktor; P C Doherty; H Koprowski
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

10.  Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.

Authors:  D C Hooper; K Morimoto; M Bette; E Weihe; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  11 in total

Review 1.  Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential.

Authors:  M A Altinoz; S Guloksuz; I Elmaci
Journal:  Clin Transl Oncol       Date:  2017-01-16       Impact factor: 3.405

2.  T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.

Authors:  Aurore Lebrun; Carla Portocarrero; Rhonda B Kean; Darryll A Barkhouse; Milosz Faber; D Craig Hooper
Journal:  J Immunol       Date:  2015-09-25       Impact factor: 5.422

3.  Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ.

Authors:  Darryll A Barkhouse; Milosz Faber; D Craig Hooper
Journal:  Virology       Date:  2014-11-19       Impact factor: 3.616

4.  Rabies: still a uniformly fatal disease? Historical occurrence, epidemiological trends, and paradigm shifts.

Authors:  Henry M Feder; Brett W Petersen; Kis L Robertson; Charles E Rupprecht
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 5.  Brain tissue-resident immune memory cells are required for long-term protection against CNS infection with rabies virus.

Authors:  Aurore Lebrun; Rhonda B Kean; D Craig Hooper
Journal:  Future Virol       Date:  2020-12-08       Impact factor: 1.831

Review 6.  Intrathecal humoral immunity to encephalitic RNA viruses.

Authors:  Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  Viruses       Date:  2013-02-15       Impact factor: 5.048

7.  Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes.

Authors:  Manjunatha Muniswamappa Venkataswamy; Shampur Narayan Madhusudana; Sampada Sudarshan Sanyal; Shaheen Taj; Ashwin Yajaman Belludi; Reeta Subramaniam Mani; Nandita Hazra
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

8.  Novel Approaches to the Prevention and Treatment of Rabies.

Authors:  C W Gnanadurai; C T Huang; D Kumar; Zhen F Fu
Journal:  Int J Virol Stud Res       Date:  2015-04-07

Review 9.  Challenges of Rabies Serology: Defining Context of Interpretation.

Authors:  Susan M Moore
Journal:  Viruses       Date:  2021-07-31       Impact factor: 5.048

10.  Emergency vaccination alleviates highly pathogenic porcine reproductive and respiratory syndrome virus infection after contact exposure.

Authors:  Xiao Li; Li Qiu; Zengqi Yang; Ruiyi Dang; Xinglong Wang
Journal:  BMC Vet Res       Date:  2013-02-09       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.